packageElafibranor

elafibranor

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Elafibranor is used to treat primary biliary cholangitis, a liver disease. It is authorised in the European Union for this indication.

Summary written by glm-5.3-flash from Wikidata Q15409440 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:elafibranor
ATC codes:A05AX06
DrugBank:DB05187
PubChem CID:9864881
Wikidata:Q15409440
formula:C22H24O4S
molar mass:384.49 g/mol (PubChem CID 9864881)
logP:5.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown